This compound is a fluorinated pyrrolidine derivative used as a pharmaceutical intermediate. It features a tert-butyl carbamate protecting group and a stereochemically defined hydroxyl group, making it suitable for integration into more complex synthetic pathways during drug development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1174020-51-9
Tert-butyl 3,5-difluoro-4-hydroxypiperidine-1-carboxylate
pharmaceutical intermediate
(3S,4R)-1-Boc-3-fluoro-4-hydroxypiperidine
pharmaceutical intermediate
Rac-tert-butyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate
pharmaceutical intermediate
1-Piperidinecarboxylic acid, 4-[[[(1R,2S,5R)-7-oxo-6-(phenylmethoxy)-1,6-diazabicyclo[3.2.1]oct-2-yl]carbonyl]amino]-, 1,1-dimethylethyl ester
pharmaceutical intermediate
2,5-Dichloro-6-methyl-3-pyridinecarboxylic acid
pharmaceutical intermediate
[[(2R,3S,4R,5S)-5-(2,4-dioxo-1H-pyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
pharmaceutical intermediate
2,4-Dichloro-3-cyano-5-fluorobenzoic acid
pharmaceutical intermediate
(3R,4R)-tert-Butyl 3-fluoro-4-hydroxypyrrolidine-1-carboxylate
pharmaceutical intermediate
tert-butyl (3S,4S)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate
KTBDFQPHEPDHQW-BQBZGAKWSA-N
CC(C)(C)OC(=O)N1C[C@@H]([C@H](C1)F)O
—